BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weng RR, Lu HH, Lin CT, Fan CC, Lin RS, Huang TC, Lin SY, Huang YJ, Juan YH, Wu YC, Hung ZC, Liu C, Lin XH, Hsieh WC, Chiu TY, Liao JC, Chiu YL, Chen SY, Yu CJ, Tsai HC. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nat Commun 2021;12:2163. [PMID: 33846331 DOI: 10.1038/s41467-021-22433-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Brown LJ, Achinger-kawecka J, Portman N, Clark S, Stirzaker C, Lim E. Epigenetic Therapies and Biomarkers in Breast Cancer. Cancers 2022;14:474. [DOI: 10.3390/cancers14030474] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu T, Guo L, Liu G, Hu X, Li X, Zhang J, Dai Z, Yu P, Jiang M, Wang J, Zhang J. Molecular Characterization of the Clinical and Tumor Immune Microenvironment Signature of 5-methylcytosine-Related Regulators in non-small Cell Lung Cancer. Front Cell Dev Biol 2021;9:779367. [PMID: 34858994 DOI: 10.3389/fcell.2021.779367] [Reference Citation Analysis]
3 Kalra RS, Soman GS, Parab PB, Mali AM, Varankar SS, Naik RR, Kamble SC, Dhanjal JK, Bapat SA. A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumors. Transl Oncol 2021;15:101257. [PMID: 34715620 DOI: 10.1016/j.tranon.2021.101257] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li L, Liu Y, Sun T, Zhou T, Bai Y, Liu X, Zhang S, Jia T, Zhao X, Wang Y. An "all-in-one" strategy based on the organic molecule DCN-4CQA for effective NIR-fluorescence-imaging-guided dual phototherapy. J Mater Chem B 2021;9:5785-93. [PMID: 34190308 DOI: 10.1039/d1tb00949d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu HL, Gong Y, Ji P, Xie YF, Jiang YZ, Liu GY. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. J Hematol Oncol 2022;15:45. [PMID: 35477416 DOI: 10.1186/s13045-022-01263-x] [Reference Citation Analysis]